130 related articles for article (PubMed ID: 32922070)
1. Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers.
Jiang P; Huang J; Deng Y; Hu J; Huang Z; Jia M; Long J; Hu Z
Cancer Manag Res; 2020; 12():7395-7403. PubMed ID: 32922070
[TBL] [Abstract][Full Text] [Related]
2. A Nomogram Model Involving Immunohistochemical Markers for Predicting the Recurrence of Stage I-II Endometrial Cancer.
Jiang P; Jia M; Hu J; Huang Z; Deng Y; Hu Z
Front Oncol; 2020; 10():586081. PubMed ID: 33585205
[TBL] [Abstract][Full Text] [Related]
3. A Nomogram Model for Predicting Recurrence of Stage I-III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors.
Jiang P; Wang J; Gong C; Yi Q; Zhu M; Hu Z
J Inflamm Res; 2022; 15():3021-3037. PubMed ID: 35645577
[TBL] [Abstract][Full Text] [Related]
4. A prediction model based on clinical and histological features for predicting recurrence in patients with stage I-II endometrial cancer after surgical treatment.
Song W; Zhao Y
Ann Diagn Pathol; 2022 Feb; 56():151861. PubMed ID: 34953233
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.
Kong W; Tu Y; Jiang P; Huang Y; Zhang J; Jiang S; Li N; Yuan R
Int J Biol Markers; 2022 Dec; 37(4):395-403. PubMed ID: 36250543
[TBL] [Abstract][Full Text] [Related]
6. Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group.
Ouldamer L; Bendifallah S; Body G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M
Br J Cancer; 2016 Nov; 115(11):1296-1303. PubMed ID: 27824810
[TBL] [Abstract][Full Text] [Related]
7. Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma.
Jiang P; Huang Y; Tu Y; Li N; Kong W; Di F; Jiang S; Zhang J; Yi Q; Yuan R
Front Oncol; 2021; 11():682925. PubMed ID: 34422634
[TBL] [Abstract][Full Text] [Related]
8. Predicting the Recurrence of Operable Cervical Cancer Patients Based on Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Classical Clinicopathological Parameters.
Jiang P; Kong W; Gong C; Chen Y; Li F; Xu L; Yang Y; Gou S; Hu Z
J Inflamm Res; 2022; 15():5265-5281. PubMed ID: 36120183
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Ki67 in Patients with Stage 1-2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor.
Jiang P; Jia M; Hu J; Huang Z; Deng Y; Lai L; Ding S; Hu Z
Onco Targets Ther; 2020; 13():10841-10850. PubMed ID: 33149602
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
[TBL] [Abstract][Full Text] [Related]
11. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
[TBL] [Abstract][Full Text] [Related]
12. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
13. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis.
Wu J; Zhang H; Li L; Hu M; Chen L; Wu S; Xu B; Song Q
Int J Gynecol Cancer; 2020 Oct; 30(10):1520-1527. PubMed ID: 32839227
[TBL] [Abstract][Full Text] [Related]
14. Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation.
Cheng Y; Dong Y; Tian W; Zhang H; Li X; Wang Z; Shan B; Ren Y; Wei L; Wang H; Wang J
J Oncol; 2020; 2020():2363545. PubMed ID: 32565798
[TBL] [Abstract][Full Text] [Related]
15. A Nomogram Model Based on Neuroendocrine Markers for Predicting the Prognosis of Neuroendocrine Carcinoma of Cervix.
Jia M; Pi J; Zou J; Feng M; Chen H; Lin C; Yang S; Deng Y; Xiao X
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769874
[TBL] [Abstract][Full Text] [Related]
16. An Externally Validated Nomogram for Predicting Lymph Node Metastasis of Presumed Stage I and II Endometrial Cancer.
Dong Y; Cheng Y; Tian W; Zhang H; Wang Z; Li X; Shan B; Ren Y; Wei L; Wang H; Wang J
Front Oncol; 2019; 9():1218. PubMed ID: 31799187
[No Abstract] [Full Text] [Related]
17. A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers.
Weinberger V; Bednarikova M; Hausnerova J; Ovesna P; Vinklerova P; Minar L; Felsinger M; Jandakova E; Cihalova M; Zikan M
Front Oncol; 2019; 9():265. PubMed ID: 31032226
[No Abstract] [Full Text] [Related]
18. Consistency of P53 immunohistochemical expression between preoperative biopsy and final surgical specimens of endometrial cancer.
Zhang J; Jiang P; Gong C; Kong W; Tu Y; Huang Y; Liu Y
Front Oncol; 2023; 13():1240786. PubMed ID: 37700829
[TBL] [Abstract][Full Text] [Related]
19. Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters.
Versluis MA; de Jong RA; Plat A; Bosse T; Smit VT; Mackay H; Powell M; Leary A; Mileshkin L; Kitchener HC; Crosbie EJ; Edmondson RJ; Creutzberg CL; Hollema H; Daemen T; de Bock GH; Nijman HW
Br J Cancer; 2015 Sep; 113(5):786-93. PubMed ID: 26217922
[TBL] [Abstract][Full Text] [Related]
20. The combined ratio of estrogen, progesterone, Ki-67, and P53 to predict the recurrence of endometrial cancer.
Jia M; Jiang P; Huang Z; Hu J; Deng Y; Hu Z
J Surg Oncol; 2020 Dec; 122(8):1808-1814. PubMed ID: 32920817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
